Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 170

Results For "NSE"

2391 News Found

Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit
Public Health | May 19, 2022

Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit

This cost-effective tool will be of immense benefit to other high burden countries as well.


Driving sustainable, enterprise-wide performance acceleration
Opinion | May 19, 2022

Driving sustainable, enterprise-wide performance acceleration

Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time


Grand Opening of Kodiak Sciences’ bioconjugation facility
Biotech | May 19, 2022

Grand Opening of Kodiak Sciences’ bioconjugation facility

Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases


IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine
Biotech | May 19, 2022

IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity


Cytel designed and led TOGETHER trial wins Clinical Trial award
News | May 18, 2022

Cytel designed and led TOGETHER trial wins Clinical Trial award

Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills


Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer
Medical Device | May 18, 2022

Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer

Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020


Innovative AI software for detection of pancreatic diseases
Digitisation | May 18, 2022

Innovative AI software for detection of pancreatic diseases

As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications


City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus
Biotech | May 18, 2022

City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus

City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours


Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years
Drug Approval | May 18, 2022

Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years

Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series


Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India
Drug Approval | May 18, 2022

Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India

Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia